Trial intelligence / Profile preview

Ovarian Morphology and Androgen Production in PCOS

NCT02145247Completed

Sponsor
University of California, San Diego
Start
May 2014
Primary completion
Feb 2017
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label trial of human chorionic gonadotropin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by University of California, San Diego. Primary endpoint: Percent Change of 17-OHP Levels From Baseline at 24 hours. Started May 2014; status: completed.

02

Drugs

human chorionic gonadotropin
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT02145247.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02145247.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call